Lucid Genomics
Berlin, DE · 1 known investors
Find your way into Lucid Genomics
Lucid Genomics provides a software platform for genomic analysis tailored to clinicians, specializing in long-read sequencing interpretation for rare disease, hereditary cancer, and pharmacogenomics diagnostics. The platform integrates variant calling, prioritization, interpretation, and reporting with HPO-based phenotype matching and advanced visualization tools for structural variants.
Founders & leadership
SM
Stefan MundlosFounder
MV
Martin VingronFounder
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountPre-seedSep 2024 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Lucid Genomics do?
- Lucid Genomics provides a software platform for genomic analysis tailored to clinicians, specializing in long-read sequencing interpretation for rare disease, hereditary cancer, and pharmacogenomics diagnostics. The platform integrates variant calling, prioritization, interpretation, and reporting with HPO-based phenotype matching and advanced visualization tools for structural variants.
- Who founded Lucid Genomics?
- Lucid Genomics was founded by Stefan Mundlos, Martin Vingron.
- Who are Lucid Genomics's investors?
- Lucid Genomics's investors include Caesar Ventures.
- Where is Lucid Genomics headquartered?
- Lucid Genomics is headquartered in Berlin, DE.